Maine Center for Cancer Medicine

Brain Cancer News

Avastin Doesn’t Improve Survival in Newly Diagnosed Glioblastoma (June 7, 2013)

In a Phase III clinical trial among patients with newly diagnosed glioblastoma, the addition of Avastin® (bevacizumab) to standard chemoradiation increased side effects and did not improve overall survival. These results were presented at the 2013 Annual... Continue Reading

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (May 22, 2013)

Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) — Agenus Inc. (Nasdaq:AGEN)... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading

Early Resection of Low-Grade Gliomas Improves Survival (November 21, 2012)

Patients in Norway with low-grade gliomas who were treated with early surgical resection had better overall survival than those treated with biopsy and watchful waiting, according to the results of a study published in the Journal of the American Medical... Continue Reading

Repeated Surgeries Improve Survival in Glioblastoma (November 13, 2012)

Patients with recurrent glioblastoma who undergo multiple surgeries to remove tumors may survive longer than those who undergo only one surgery, according to the results of a study published in the Journal of Neurosurgery. Glioblastoma mutiforme (GBM)... Continue Reading

Chemotherapy Plus Radiation Improves Survival for Anaplastic Oligodendroglioma (October 29, 2012)

Some patients with anaplastic oligodendroglioma live substantially longer if they are treated with a combination of chemotherapy and radiation instead of radiation alone, according to the long-term results of two studies published in the Journal of Clinical... Continue Reading

Temodar and Hypofractionated Radiotherapy Appropriate for Elderly Patients with Glioblastoma (August 21, 2012)

Both Temodar® (temozolomide) and hypofractionated radiotherapy should be considered as standard treatment options in elderly patients with glioblastoma, according to the results of a study published in the Lancet Oncology. Glioblastoma multiforme (GBM)... Continue Reading

Childhood CT Scans Linked to Leukemia and Brain Cancer Later in Life (June 20, 2012)

Children and young adults who undergo multiple computed tomography (CT) scans have an increased risk of leukemia and brain tumors in the decade following their first scan, according to the results of a study published in The Lancet. CT scans are a common... Continue Reading

Chemotherapy Plus Radiation Extends Survival in Patients with Anaplastic Oligodendroglial Tumors (June 13, 2012)

Treatment with combination chemotherapy after radiation therapy delayed tumor growth and extended survival in patients with anaplastic oligodendroglial tumors, according to the results of a phase III study presented at the 2012 annual meeting of the American... Continue Reading

Latest Brain Cancer News By Stage


General Brain Cancer

Avastin Doesn’t Improve Survival in Newly Diagnosed Glioblastoma (June 7, 2013)

In a Phase III clinical trial among patients with newly diagnosed glioblastoma, the addition of Avastin® (bevacizumab) to standard chemoradiation increased side effects and did not improve overall survival. These results were presented at the 2013 Annual... Continue Reading

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (May 22, 2013)

Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) — Agenus Inc. (Nasdaq:AGEN)... Continue Reading

Early Resection of Low-Grade Gliomas Improves Survival (November 21, 2012)

Patients in Norway with low-grade gliomas who were treated with early surgical resection had better overall survival than those treated with biopsy and watchful waiting, according to the results of a study published in the Journal of the American Medical... Continue Reading

Repeated Surgeries Improve Survival in Glioblastoma (November 13, 2012)

Patients with recurrent glioblastoma who undergo multiple surgeries to remove tumors may survive longer than those who undergo only one surgery, according to the results of a study published in the Journal of Neurosurgery. Glioblastoma mutiforme (GBM)... Continue Reading

Chemotherapy Plus Radiation Improves Survival for Anaplastic Oligodendroglioma (October 29, 2012)

Some patients with anaplastic oligodendroglioma live substantially longer if they are treated with a combination of chemotherapy and radiation instead of radiation alone, according to the long-term results of two studies published in the Journal of Clinical... Continue Reading

More General Brain Cancer